What are the recent financial highlights of ARCHEAN CHEMICAL IND LTD?

ARCHEAN CHEMICAL IND LTD recently reported a total revenue of ₹979.35 Cr and a net profit margin of 16.97%. These metrics reflect the company’s consistent financial performance.

What is the dividend yield of ARCHEAN CHEMICAL IND LTD?

ARCHEAN CHEMICAL IND LTD offers a dividend yield of 1.05%, with a dividend rate of ₹5.5 per share.

What are the key financial metrics of ARCHEAN CHEMICAL IND LTD?

Key financial metrics include a trailing P/E ratio of 37.802975, forward P/E of 11.243918, book value of ₹143.034, price-to-book ratio of 3.5547495, and a market capitalization of ₹62.78 billion.

What does ARCHEAN CHEMICAL IND LTD do?

Archean Chemical Industries Limited manufactures and sells specialty marine chemicals in India and internationally. It offers bromine for use in pharmaceuticals, agrochemicals, flame retardants, and water treatment products, as well as oil and gas, and energy storage industries; industrial salt for chloralkali chemical, food and beverage, water treatment, and oil and gas industries; and sulphate of potash, an inorganic salt for agrochemicals, medical, glass, cosmetics, etc. Industries. The company was founded in 2003 and is based in Chennai, India.

Loading...

₹ 0 0.00%

Loading... BSE: Loding... NSE: Aci

About

Loading... ^[1]

Website BSE NSE

Market Cap ₹ 0 Cr.
Current Price ₹ 0
High / Low ₹ 0 / 0
Stock P/E
Dividend Yield 0 %
ROE 0 %
EPS 0
P/B Ratio 0
Net Profit Margin 0 %
Debt to Equity 0
ROCE 0 %
Interest Coverage 0 %

Stock News - Aci

Latest updates related to Aci

Sr No.	Title	Sentiment
1	NGL Fine-Chem factories operating at normal capacity Indian Chemical News	🔄
2	Schaeffler Addressing Challenges & Embracing Opportunities In Evolving Automotive Market Mobility Outlook	🔄
3	'Elon Musk has got to go': Why are Tesla facilities being attacked worldwide? Know in 10 points The Economic Times	🔄
4	India's Syngene International acquires first US biologics facility for $36.5 mln ReutersSyngene International Makes Strategic Foray into US Biologics Manufacturing GrowwSyngene acquires first manufacturing site in US MoneycontrolSyngene International acquires its first biologics unit in US for $36.5 mn Business StandardSyngene acquires first US facility from Emergent Manufacturing BusinessLine$50 million deal! THIS Indian healthcare firm acquires first US biologics facility ET NowEmergent BioSolutions sells Baltimore facility to Syngene Investing.com IndiaRs 465 Crore Bet on the Future: Big Pharma’s Massive US Expansion in the Works! Dalal Street Investment JournalSyngene acquires its first biologics site in Baltimore, USA Business Standard	🔄
5	Syngene International shares in focus on acquiring first US biologics facility for $36.5 million The Economic Times	🔄
6	Syngene International acquires first US biologics facility in the USA CNBCTV18	🔄
7	Syngene Acquires First US Manufacturing Facility Contract Pharma	🔄
8	Syngene acquires first US biologics site for $50 mn to expand capacity Business Standard	🔄
9	India’s Syngene International acquires first US biologics facility for $36.5 million ThePrint	🔄
10	Syngene Acquires its First Manufacturing Facility in the US PR Newswire	🔄

Peer Comparison

Macro Industry: Loading.. | Sector: Loading.. | Industry: Loading.. | Basic Industry: Loading..

Loading peers table...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Loading data...

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Loading Profit & Loss data...

Compounded Sales Growth
10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth
10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR
10 Years:
5 Years:
3 Years:
1 Year:

Return on Equity
10 Years:
5 Years:
3 Years:
Last Year:

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Shareholding Pattern

Numbers in percentages

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Delivery Data

Insider Data

Technical Data

Static Application Security Testing

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls

Explore More Stocks

SAHAJSOLAR GLAXO ZFCVINDIA KOTAKBANK NAVKARCORP MASTEK RADIOWALLA NIRAJ HYBRIDFIN AVALON